Clinical Trial

RNA Editing as a Biomarker of Antidepressant Response in Unipolar and Bipolar Depression (EDIT-ANDRE)

Name: RNA Editing as a Biomarker of Antidepressant Response in Unipolar and Bipolar Depression (EDIT-ANDRE) — clinical trial record (NCT07266545)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 4

View on ClinicalTrials.gov →

Summary

The purpose of this research is to understand how changes in RNA editing relate to treatment response in unipolar and bipolar depression.

Protocol Amendment History 1 change

minor Trial arms changed: 2 -> 1 2026-06-23

Trial Details

NCT Number	NCT07266545
Lead Sponsor	Mayo Clinic
Conditions	Unipolar Depression, Bipolar Depression
Enrollment	120 participants
Start Date	2026-02-17
Primary Completion	2028-12-31 (estimated)
Study Completion	2030-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-06-22